➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Moodys
Medtronic
Colorcon
McKesson

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

Details for Patent: 9,968,553


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,968,553 protect, and when does it expire?

Patent 9,968,553 protects EPANED KIT and is included in one NDA.

This patent has five patent family members in five countries.

Summary for Patent: 9,968,553
Title:Enalapril compositions
Abstract: Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
Inventor(s): Rajewski; Lian G. (Lawrence, KS), Rajewski; Roger A. (Lawrence, KS), Haslam; John L. (Lawrence, KS), Heppert; Kathleen (Lawrence, KS), Beckloff; Michael C. (Leawood, KS), Segrave; Frank (Dublin, OH), Mauro; Robert (Miller Place, NY), Colabuono; Peter (Las Vegas, NV)
Assignee: SILVERGATE PHARMACAUTICALS, INC. (Greenwood Village, CO) UNIVERSITY OF KANSAS (Lawrence, KS)
Application Number:15/850,732
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,968,553
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 9,968,553

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Silvergate Pharms EPANED KIT enalapril maleate FOR SOLUTION;ORAL 204308-001 Aug 13, 2013 DISCN Yes No ⤷  Try it Free ⤷  Try it Free METHOD OF TREATMENT OF HEART FAILURE ⤷  Try it Free
Silvergate Pharms EPANED KIT enalapril maleate FOR SOLUTION;ORAL 204308-001 Aug 13, 2013 DISCN Yes No ⤷  Try it Free ⤷  Try it Free TREATMENT OF HYPERTENSION ⤷  Try it Free
Silvergate Pharms EPANED KIT enalapril maleate FOR SOLUTION;ORAL 204308-001 Aug 13, 2013 DISCN Yes No ⤷  Try it Free ⤷  Try it Free METHOD OF TREATING LEFT VENTRICULAR DYSFUNCTION ⤷  Try it Free
Silvergate Pharms EPANED KIT enalapril maleate FOR SOLUTION;ORAL 204308-001 Aug 13, 2013 DISCN Yes No ⤷  Try it Free ⤷  Try it Free METHOD OF TREATING HYPERTENSION ⤷  Try it Free
Silvergate Pharms EPANED KIT enalapril maleate FOR SOLUTION;ORAL 204308-001 Aug 13, 2013 DISCN Yes No ⤷  Try it Free ⤷  Try it Free TREATMENT OF HEART FAILURE ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,968,553

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil 112015007592 ⤷  Try it Free
Canada 2887379 ⤷  Try it Free
European Patent Office 2903690 ⤷  Try it Free
Spain 2770403 ⤷  Try it Free
World Intellectual Property Organization (WIPO) 2014055667 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Mallinckrodt
Boehringer Ingelheim
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.